Download Professor Wilding is Head of the Department of Obesity and

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Fetal origins hypothesis wikipedia , lookup

Nutriepigenomics wikipedia , lookup

Epigenetics of diabetes Type 2 wikipedia , lookup

Transcript
Professor Wilding is Head of the Department of Obesity and
Endocrinology at the University of Liverpool, UK. He trained in
medicine in Southampton and at the Hammersmith Hospital, London
where he also undertook three years laboratory-based research into
the neurobiology of obesity and diabetes. He has worked at
University Hospital Aintree, Liverpool since 1996 and as Professor of
Medicine since 2005. He has published over two hundred papers,
chapters and review articles related to his clinical and laboratory
research interests in type 2 diabetes and obesity. His clinical research
focuses on the pathophysiology of obesity and diabetes and
evaluation of new treatments. He is Chair of the UK National Clinical
Research Network Metabolic and Endocrine Speciality Group. He
leads specialist services for severe obesity at University Hospital
Aintree - recently designated as a Centre for Obesity Management by
the European Association for the Study of Obesity.
Dr Stephens has been Consultant Physician responsible for diabetes
care in Trafford since 1985. He qualified in 1972 from Westminster
Hospital Medical School, London, and has worked in Manchester since
1978, initially in the department of medicine at Manchester Royal
Infirmary before moving to Trafford. He led the development of the
new Trafford Diabetes Centre, including the successful £500,000 fundraising appeal for the new build, which opened in 2008. He led
Trafford to the finals of the ‘Diabetes Team of the Year Award' in
2007. He is President of the local branch of Diabetes UK and has taken
part in many charitable events raising money for Diabetes UK, such as
The Great North Run. Current projects include the integration of IT
systems to improve communication and patient care, structured
education programmes for Type 1 & Type 2 diabetes, and
championing for the greater use of insulin pumps. Dr Stephens’
research activity relates to the therapeutics of diabetes
Professor Vora is Consultant Physician/ Professor at the Royal
Liverpool University Hospital and the University of Liverpool. He
qualified from the University of Cambridge, and undertook
substantive training in diabetes as a Research Fellow and then
Lecturer at the University of Wales College of Medicine. He then
undertook a period as Fulbright Senior Fellow at Oregon Health
Sciences University. He has been a Consultant Physician at the Royal
Liverpool University Hospital since 1993, specialising in Diabetes and
Endocrinology. He has served on many advisory panels, the National
Institute for Clinical Excellence, and the Diabetes and Renal National
Service Frameworks. Prof Vora has on-going research interests in the
development of/ screening for/ treatment of diabetic retinopathy;
renal haemodynamics/function and hypertension in Type 2 diabetes,
the prevention of renal disease in diabetes and the physiological
aspects of treatment of Type 2 diabetes. He has published extensively
in these fields.
Professor Kumar has 3 decades of experience in his field and has held
distinguished positions with a number of professional bodies, like
Research Society for the Study of Diabetes in India, Diabetes India,
and Endocrine Society of India. He is the Hon. Professor and Head of
Department at M. S. Ramaiah Medical College, India. He is also
consultant endocrinologist at Centre for diabetes & endocrine care,
Bangalore Diabetes Hospital & Director of PRIMER-an organisation
dedicated to innovation in medical education and research.
His current areas of clinical interest are the epidemiology of diabetes,
dyslipidaemia, Diabetes in the young and genetics, and have a
number of publications in these fields. He is editor of Practice Impact,
a newsletter for general practitioners, and is a member of the
editorial boards of Indian Clinical Updates – Diabetes, IJDDC (journal
of RSSDI) and Diabetes & Metabolic Syndrome: Clinical Research &
Reviews